AIM's Serum-Free Iterative Rabies Vaccine Receives Acceptance for Market Registration; Institutions Predict Significant Valuation Recovery Potential for the Company HONG KONG, April 8, 2025 /PRNewswire/ — AIM Vaccine Co., Ltd. (06660.HK),… CISION PRNewswireApril 8, 2025
Press ReleasePRA Group Announces Leadership Succession Plan Martin Sjolund appointed President and Chief Executive Officer, effective June 17, 2025… CISION PRNewswireApril 8, 2025
Acclime acquires The Advisory Group to strengthen service capabilities in Australasia AUCKLAND, New Zealand, April 8, 2025 /PRNewswire/ — Acclime, a leading global… CISION PRNewswireApril 8, 2025
Press ReleaseCAS and Cleveland Clinic collaborate to accelerate research through advanced AI and quantum computing COLUMBUS, Ohio, April 8, 2025 /PRNewswire/ — CAS, a division of the… CISION PRNewswireApril 8, 2025
Press ReleaseKia Design Presents Opposites United: Eclipse of Perceptions at Milan Design Week 2025 Kia Design returns to Milan Design Week for third consecutive year, providing… CISION PRNewswireApril 8, 2025
Press ReleaseBeLive Holdings Announces Closing of Approximately $10,000,000 Initial Public Offering SINGAPORE, April 8, 2025 /PRNewswire/ — BeLive Holdings (the "Company" or "BeLive"),… CISION PRNewswireApril 7, 2025
Canada Leads: Canada's No. 1 Hospital Announces Strategy to Attract World's Most Promising Scientists, Drive Health Innovation and Economic Growth TORONTO, April 8, 2025 /PRNewswire/ — In a bold move to position… CISION PRNewswireApril 7, 2025
Press ReleaseBosch establishes company with the synthetic diamond solutions provider Element Six Quantum sensors: Partnership to extend innovation leadership Element Six and the technology… CISION PRNewswireApril 7, 2025
